CAITLIN KRIEGER: Open Payments
NPI 1558764548 · MADISON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,895 in 103 payments from 14 companies in 2025. Trend: 2023 $1,143 · 2024 $1,376 · 2025 $1,895
Food & beverage: $1,895
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $451 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $253 |
| Phathom Pharmaceuticals, Inc. | 14 | $155 |
| Ardelyx, Inc. | 7 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $140 |
| PFIZER INC. | 7 | $138 |
| Janssen Biotech, Inc. | 5 | $113 |
| GENZYME CORPORATION | 3 | $107 |
| VIVUS LLC | 4 | $91 |
| Madrigal Pharmaceuticals | 3 | $82 |
Products named: XIFAXAN, VOQUEZNA, IBSRELA, RINVOQ, DUPIXENT, LINZESS, ENTYVIO, XELJANZ.
Industry payments across GA — which companies pay providers there.
